SignalChem enters a clinical trial collaboration with Merck to evaluate the effect of SLC-391 in combination with KEYTRUDA® (pembrolizumab) in advanced non-small cell lung cancer
March 25, 2021

March 25, 2021
March 23, 2021
March 23, 2021
March 22, 2021
March 22, 2021
March 15, 2021
March 15, 2021
March 10, 2021
March 9, 2021
April 17, 2026
Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high ...
April 15, 2026
The Board of Directors of Medix Biochemica, a global leader in the supply of mission critical components for the in vitro diagnostics (IVD) industry, ...
April 14, 2026
Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s diseas...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225